切换至 "中华医学电子期刊资源库"
高级检索
中华临床医师杂志(电子版)

中华临床医师杂志(电子版) ›› 2018, Vol. 12 ›› Issue (02) : 90 -94. doi: 10.3877/cma.j.issn.1674-0785.2018.02.006

所属专题： 文献；

临床研究

15例肺梭形细胞癌患者的临床特征及预后
邵志鹏1, 赵松1,†(), 张仁锋1, 魏创业1, 龙勇1   
  1. 1. 450052　郑州大学第一附属医院胸外一科，郑州市胸部肿瘤重点实验室
  • 收稿日期:2017-08-21 出版日期:2018-01-15
  • 通信作者: 赵松

Clinical characteristics and prognosis of fifteen cases of spindle cell carcinoma of the lung

Zhipeng Shao1, Song Zhao1,†(), Renfeng Zhang1, Chuangye Wei1, Yong Long1   

  1. 1. Department of Thoracic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou Key Laboratory of Thoracic Oncology, Zhengzhou 450052, China
  • Received:2017-08-21 Published:2018-01-15
  • Corresponding author: Song Zhao
  • About author:
    Corresponding author: Zhao Song, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

邵志鹏, 赵松, 张仁锋, 魏创业, 龙勇. 15例肺梭形细胞癌患者的临床特征及预后[J/OL]. 中华临床医师杂志(电子版), 2018, 12(02): 90-94.

Zhipeng Shao, Song Zhao, Renfeng Zhang, Chuangye Wei, Yong Long. Clinical characteristics and prognosis of fifteen cases of spindle cell carcinoma of the lung[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(02): 90-94.

目的

探讨肺梭形细胞癌的临床病理特征及预后。

方法

收集2012年1月至2014年12月郑州大学第一附属医院确诊的15例肺梭形细胞癌患者的临床资料，应用Kaplan-Meier法计算生存率并绘制生存曲线。

结果

6058例肺癌患者中15例确诊为肺梭形细胞癌，其中男性12例，女性3例，中位年龄58岁，9例有大量吸烟史。CT显示肿瘤平均直径（53.6±20.3）mm，其中2例侵犯相邻结构，12例为外周型。7例患者行PET-CT，肿块平均标准摄取值为12.8±4.3，高于其他同分期的非小细胞型肺癌（NSCLC）（P=0.003）。中位生存期为12.1个月，接受外科治疗的11例患者中复发和转移较常见，手术治疗患者较非手术者生存时间更长（P=0.01），术后化疗患者较未行化疗手术患者在生存时间未能明显获益（P=0.03）。

结论

肺梭形细胞癌极为罕见，侵袭性强，易复发、转移，对化疗反应差，目前早期手术为主要治疗办法。

关键词: 肺梭形细胞癌, 临床特征, 治疗, 预后
Objective

To analyze the clinical characteristics and prognosis of spindle cell carcinoma of the lung (SpCC).

Methods

A total of 15 patients were hospitalized at our hospital between 2012 and 2014 for treatment of SpCC. We retrospectively analyzed their clinical characteristics and prognosis.

Results

Fifteen of 6058 patients with primary lung cancer were diagnosed with SpCC. Of them, twelve were male and three were female, with a median age of 58.0 years. Nine were current- or ex-smokers with substantial smoking histories. Computed tomography (CT) findings revealed that the tumors were quite large (mean diameter, 53.6±20.3 mm), with three cases having invasion of adjacent structures and 12 tumors located peripherally. Positron emission tomography-CT (PET-CT) was performed in seven patients, and the standardized uptake value (SUV) tended to be high (12.8±4.3), which was significantly higher than other NSCLC cases at the same stage (P=0.003). The median survival was 12.1 months. In 11 patients who underwent surgical treatment, recurrence and metastases frequently occurred. Patients who had undergone surgical resection survived longer than those who did not (P=0.01). Postoperative chemotherapy did not significantly prolong the survival time (P=0.03).

Conclusions

SpCC of the lung is extremely rare and has strong malignant potential with frequent recurrence and distant metastases. Response to chemotherapy is generally poor. Surgical treatment at early stage might result in better prognosis.

Key words: Spindle cell carcinoma of the lung, Clinical characteristics, Therapy, Prognosis
表1 15例梭形细胞癌患者的临床特点
例号 性别 年龄 吸烟指数 症状 肿瘤最大直径（mm） 病变部位 PET-CT标准摄取值（SUV） 临床分期 病理分期 化疗 随访时间（月）
1 男 63 60 C＋E 52 外周 10.6 T3N0M0 ⅡB T3N0M0 ⅡB 否 13.3
2 男 51 0 C＋CP 65 外周 ? T3N1M0 ⅢA T3N1M0 ⅢA 是 5.0
3 男 57 30 C＋F 41 外周 7.9 T3N1M0 ⅢA T3N1M0 ⅢA 是 10.6
4 男 46 0 C＋CD＋E 38 外周 15.6 T2aN0M0 ⅠB T2aN1M0 ⅡB 否 11.5
5 男 59 50 CD＋CP 71 外周 ? T4N0M0 ⅢA T4N1M0 ⅢA 是 15.6
6 男 59 0 H 34 外周 ? T2aN0M0 ⅠB T2aN0M0 ⅠB 否 25.4
7 男 47 20 CP 29 中央 ? T1cN0M0 ⅠA T1CN0M0 ⅠA 否 21.9
8 男 61 60 CP＋H＋F 60 外周 ? T3N0M0 ⅡB T3N1M0 ⅢA 是 2.1
9 男 62 0 -- 26 外周 ? T1bN0M0 ⅠA T1bN0M0 ⅠA 否 14.3
10 女 57 20 C＋E＋CD 61 外周 11.7 T3N0M0 ⅡB T3N1M0 ⅢA 否 8.2
11 女 51 0 C＋E 41 中央 20.0 T2bN0M0 ⅡA T2bN0M0 ⅡA 否 18.8
12 男 81 120 C＋E＋H＋F 56 外周 8.9 T3N0M0 ⅡB ? 是 10.1
13 女 67 0 CD 51 外周 ? T3N1M0 ⅢA ? 是 12.1
14 男 53 20 CD＋CP 95 外周 ? T4N2M0 ⅢB ? 是 3.7
15 男 79 50 C＋CD 83 中央 15.2 T4N1M1b ⅣA ? 是 1.8
图1 15例肺梭形细胞癌患者的总生存曲线
图2 4例行术后化疗的肺梭形细胞癌患者和7例术后未行化疗患者的生存曲线（P=0.03）
图3 11例经手术治疗的肺梭形细胞癌患者与4例未手术患者的生存曲线（P=0.01）
1
Maggiore C，Mule A，Fadda G，et al． Histological classification of lung cancer [J]. Rays, 2004, 29(4): 353-355.
2
Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases [J]. Am J Surg Pathol, 2003, 27(3): 311-324.
3
Terada T. Spindle cell carcinoma of the lung: Frequency, clinical features, and immunohistochemical studies of three cases [J]. Respiratory Medicine CME, 2010, 3(4): 241-245．
4
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification [J]. J Thorac Oncol, 2015,10(9):1243-1260.
5
Travis WD. Classification of lung cancer [J]. Semin in Roentgenol, 2011, 46(3):178-186.
6
Yendamuri S, Caty L, Pine M, et al. Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis [J]. Surgery, 2012, 152(3): 397-402.
7
Kontic M, Stojsic J, Stevic R, et al. Could spindle cell lung carcinoma be considered and treated as sarcoma, according to its clinical course, morphology, immunophenotype and genetic finding? [J]. Pathol Oncol Res, 2013, 19(1): 129-133.
8
Kim TS, Han J, Lee KS, et al. CT findings of surgically resected pleomorphic carcinoma of the lung in 30 patients [J]. AJR Am J Roentgenol, 2005, 185(1): 120-125.
9
Kim TH, Kim SJ, Ryu YH, et al. Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings [J]. Radiology, 2004, 232(2): 554-559.
10
Venissac N, Pop D, Lassalle S, et al. Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease? [J]. J thorac cardiovasc surg, 2007, 134(3): 619-623.
11
Sugawara E, Kumagai J, Sanai A, et al. A Patient with pulmonary spindle cell carcinoma [J]. Haigan, 2010, 50(2): 178-185.
12
Tonai K, Kitasato Y, Kawakami T, et al. Autopsy case of rapidly progressive pulmonary spindle cell carcinoma with multiple metastases to the brain and pancreas [J]. Nihon Kokyuki Gakkai Zasshi, 2009, 47(9): 828-832.
13
Tournoy KG, Maddens S, Gosselin R, et al. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study [J]. Thorax, 2007, 62(8): 696-701.
14
Hamanaka K, Toishi M, Nishimura H. A case of rapidly progressing pulmonary spindle cell carcinoma [J]. Japanese Journal of Lung Cancer, 2005, 45(4): 363-366.
15
Yendamuri S, Caty L, Pine M, et al. Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis [J]. Surgery, 2012, 152(3): 397-402.
16
Matsui K, Kitagawa M. Spindle cell carcinoma of the lung. A clinicopathologic study of three cases [J]. Cancer, 1991, 67(9): 2361-2367.
17
Sugano T, Mori M, Namba Y, et al. A case of sarcomatoid carcinoma of the lung successfully treated with carboplatin, paclitaxel and bevacizumab [J]. Nihon Kokyuki Gakkai zasshi, 2011, 49(4): 304-308.
18
Mainwaring MG, Poor C, Zander DS, et al. Complete remission of pulmonary spindle cell carcinoma after treatment with oral germanium sesquioxide [J]. Chest, 2000, 117(2): 591-593.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(08): 778-784.
[2] 严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[3] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[7] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[8] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[9] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[10] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[11] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[12] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[13] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号